Abstract Claims Description Full Text

Abstract

Disclosed are compounds of the formula: ##STR1## or pharmaceutically acceptable salts thereof; wherein n is zero or 1; R4, R5, R6 are independently hydrogen, nitro, amino, halo, haloalkyl, cyano, alkyl, cycloalkyl, alkenyl, alkynyl, azido, acylamino, alkylsulfonyl, aryl, substituted aryl, heteroaryl, alkoxy, trialkylsilyl-substituted alkoxy, aryloxy, substituted aryloxy, heteroaryloxy, a heterocyclic group, a heterocyclicoxy group, aralkoxy, or haloalkoxy; and Rc and Rd are defined in the specification. These compounds have high binding to the glycine site of the NMDA receptor. Also disclosed are methods of treating pathophysiologic conditions associated with neuronal degeneration, convulsions, anxiety, chronic pain, pyschosis, opiate tolerance, and inducing anesthesia.

Other References

• Winterfeld, Chemical Abstracts 72:78970 (1970), see especially RN 25710-21-8
• Albert, A. et al., "Pteridine studies. VIII. Degradation of pteridine. Methylation of the hydroxypteridines and degradation of the products," Chem. Abs. 51:1977b (1957)
• Albert, A. et al., "Pteridine studies. X. Pteridines with more than one hydroxy or amino group," Chem. Abs. 51:6654c (1957)
• Albert, A. et al., "Pteridine Studies. Part XXXV. The Structure of the Hydrated Dimer Formed by the Action of Dilute Acid on 4-Methylpteridine," J. Chem. Soc. (C):1181-1187 (1968)
• Bigge, C. F. and P. A. Boxer, "Chapter 2. Neuronal Cell Death and Strategies for Neuroprotection," Ann. Rep. Med. Chem. 29:13-22 (Aug. 1994)
• Boast, C. A. et al., "The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils," Brain Res. 442:345-348 (1988)
• Boutte, D. et al., "Etude des mono et dihydroxy-pyrido-›2.3-b! et ›3.4-b! pyrazines et synthese de la dioxo-1.4 tetrahydro-1.2.3.4 pyrido-›2'.3':5.6! pyrazino-›2.3-d! pyridazine; " C. R. Acad. Sc. Paris 273:1645-1648 (1971)
• Brady, K. T. et al., "Stereoisomers of N-Allylnormetazocine: Phencyclidine-Like Behavioral Effects in Squirrel Monkeys and Rats," Science, 215:178-180 (1982)
• Burton, D. E. et al., "Halogeno-o-phenylenediamines and Derived Heterocycles. Part I. Reductive Fission of Benzotriazoles to o-Phenylenediamines," J. Chem. Soc. (C):1268-1280 (1968)
• Choi, D. W. et al., "Glutamate Neurotoxicity in Cortical Cell Culture," J. Neurosci. 7(2):357-368 (1987)
• Church, J. et al., "Ketamine and MK-801 as Neuroprotective Agents in Cerebral Ischemia/Hypoxia," in: Sigma and Phencyclidine-Like Compounds as Molecular Probes in Biology, Domino, E. F. and J.-M. Kamenka, eds., NPP Books: Ann Arbor (1988)
• Clark, J. et al., "Heterocyclic Studies. Part VIII. 2-Phenylpteridine and Some Related Compounds," J. Chem. Soc. (C):1408-1412 (1969)
• Claek, J. et al., "Heterocyclic Studies. Part X. 4-Phenylpteridine and Some Methyl Derivatives," J. Chem. Soc. (C):1883-1886 (1969)
• Collins, R. C., "Selective Vulnerability of Brain: New Insights from the Excitatory Synapse," Metabolic Brain Dis. 1(4):231-240 (1986)
• Collins, R. C. et al., "Selective Vulnerability of the Brain: New Insights into the Pathophysiology of Stroke," Ann. Internal Med. 110(12):992-1000 (1989)
• Daines, R. A. et al., "Trisubstituted Pyridine Leukotriene B₄ Receptor Antagonists: Synthesis and Structure-Activity Relationships," J. Med. Chem. 36:3321-3332 (Nov. 1993)
• Decker, T. and M.-L. Lohmann-Matthes, "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity," J. Imm. Meth. 15:61-69 (1988)
• Dickenson, A. H. and E. Aydar, "Antagonism at the Glycine site on the NMDA receptor reduces spinal nociception in the rat," Neruosci. Lett. 121:263-266 (1991)
• Dubuisson, D. and S. G. Dennis, "The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats," Pain 4:161-174 (1977)
• Fletcher, E. J. and D. Lodge, "Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phophonovalerate (D-AP5) on rat cortical slices," Eur. J. Pharmcol. 151:161-162 (1988)
• Fletcher, E. J. et al., "Involvement of Glycine in Excitatory Neurotransmission," in: Glycine Neurotransmission, Ottersen, O. P. and J. Storm-Mathisen, eds., John Wiley & Sons Ltd. (1990)
• Gill, R. et al., "Systemic Administration of MK-801 Protects Against Ischemia-Induced Hippocampal Neurodegeneration in the Gerbil," J. Neurosci. 7(10):3343-3349 (1987)
• Globus, M. Y.-T. et al., "Comparative Effect of Transient Global Ischemia on Extracellular Levels of Glutamate, Glycine, and γ-Aminobutyric Acid in Vulnerable and Nonvulnerable Brain Regions in the Rat," J. Neurochem. 57(2):470-478 (1991)
• Gottlieb, R. and W. Pfleiderer, "Synthese und elektrochemisches Verhalten von 6,7-Dioxo-tetrahydropteridinen und 2,3-Dioxotetrahydropyrido-pyrazinen," Chem. Ber.111:1763-1779 (1978)
• Gray, N. M. et al., "Novel Indole-2-carboxylates as Ligands for the Strychnine-Insensitive N-Methyl-D-aspartate-Linked Glycine Receptor," J. Med. Chem. 34:1283-1292 (1991)
• Haley, J. E. et al., "Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat," Brain Res. 518:218-226 (1990)
• Huettner, J. E. and B. P. Bean, "Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels," Proc. Natl. Acad. Sci. USA 85:1307-1311 (1988)
• Huidobro, F. et al., "Studies on Tolerance Development to Single Doses of Morphine in Mice," J. Pharmacol. Exp. Ther. 198(2):318-329 (1976)
• Hunger, A. et al., "1-Aminoalkyl-7-azabenzimidazoles," Chem. Abstr. 63:14876 (1965)
• Israel, M. and A. R. Day, "Preparation of Pyrido-(2,3)-pyrazines, Pyrido-(3,4) pyrazines and Imidazo-(b)-pyridines," J. Org Chem. 24:1455-1460 (1959)
• Johnson, J. W. and P. Ascher, "Glycine potentiates the NMDA response in cultured mouse brain neurons," Nature 325:529-531 (1987)
• Jones, B. J. et al., "The potential anxiolytic activity of GR38032F, a 5-HT₃ -receptor antagonist," Br. J. Pharmacol. 93:985-993 (1988)
• Kaye, I. A., "Some Substituted Pyrido(2,3)pyrazines," J. Med. Chem. 7(2):240-241 (1964)
• Keana, J. F. W. et al., "Synthesis and characterization of a series of diaryguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties," Proc. Natl. Acad. Sci. USA 86:5631-5635 (1989)
• Kemp, J. A. et al., "7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex," Proc. Natl. Acad. Sci. USA 85:6547-6550 (1988)
• Kessler, M. et al., "A Glycine Site Associated with N-Methyl-D-Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists," J. Neurochem. 52(4):1319-1328 (1989)
• Koek, W. et al., "MK-801, a Proposed Noncompetitive Antagonist of Excitatory Amino Acid Nuerotransmission, Produces Phencyclidine-Like Behavioral Effects in Pigeons, Rats and Rhesus Monkeys," J. Pharmacol. Exp. Ther. 245(3):969-974 (1988)
• Kornetsky, C. and G. Bain, "Morphine: Single-Dose Tolerance," Science 162:1011-1012 (1968)
• Kress, T. J. et al., "Selective Chlorinations in Sulfuric Acid, Synthesis of Some 2-Amino-5-chloro-, 2-Amino-3-chloro-and 2-Amino-3,5-dichloropyridines," J. Org. Chem. 41(1):93-96 (1976)
• Kulagowski, J. J. et al., "3'-(Arylmethyl)-and 3'-(Aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor," J. Med. Chem. 37:1402-1405 (May 1994)
• Landon, R. M. and R. J. Robbins, "Somatostatin Release from Dissociated Cerebral Cortical Cell Cultures," Meth. Enzymol. 124:412-424 (1986)
• Leeson, P. D., "Glycine-Site N-Methyl-D-Aspartate Receptor Antagonists," in: Drug Design for Neuroscience, Kozikowski, A. P., ed., Raven Press, Ltd.: New York, pp. 339-381 (Jul. 1993)
• Leeson, P. D. and L. L. Iverson, "The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential," J. Med. Chem. 37(24):4053-4067 (Nov. 1994)
• Leo, A. et al., "Partition Coefficients and Their Uses," Chem. Rev. 71(6):525-616 (1971)
• Lonsdale, D., "Effect of Thiamine Terahydrofurfuryl Disulfide on Audiogenic Seizures in DBA/2J Mice," Dev. Pharmacol. Ther. 4:28-36 (1982)
• Lutfy, K. and B. C. Yoburn, "The Role of Opioid Receptor Density in Morphine Tolerance," J. Pharmacol. Exp. Ther. 256(2):575-580 (1991)
• Lutfy, K. et al., "Blockade of morphine-induced analgesia and tolerance in mice by MK-801," Brain Res. 616:83-88 (Jun. 1993)
• MacDonald, J. F. et al., "Use-Dependent Block of Excitatory Amino Acid Currents in Cultured Neurons by Ketamine," J. Neurophysiol. 58(2):251-266 (1987)
• Marek, P. et al., "Excitatory amino acid antagonists (kynurenic ancid and MK-801) attenuate the development of morphine tolerance in the rat," Brain Res. 547:77-81 (1991)
• McFarlane, M. D. and D. M. Smith, "A New Route to N-Hydroxyquinoxaline-2,3-Diones and Some Aza-Analogues," Tetrahedron Lett. 28(50):6363-6366 (1987)
• McNamara, D. et al., "5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors," Neurosci. Lett. 120:17-20 (1990)
• Miller, B. et al., "Potentiation of NMDA receptor currents by arachidonic acid," Nature 355:722-725 (1992)
• Monn, J. A. and D. D. Schoepp, "Chapter 6. Recent Progress in Excitatory Amino Acid Research," Ann. Rep. Med. Chem. 29:53-64 (Aug. 1994)
• Pfleiderer, W. and R. Lohrmann, "Pteridines. XV. Synthesis of 2-amino-4-alkoxy-7-oxodihydropteridines," Chem. Abstr. 56:4752b (1962)
• Reynolds, I. J. and R. J. Miller, "Allosteric Modulation of N-Methyl-D-Aspartate Receptors," Adv. Pharmacol. 21:101-126 (1990)
• Sakamoto, S. et al., "Preparation of diketopiperazines as glutamate receptor antagonists," Chem. Abs. 117(25): Abstract No. 251367d (1992)
• Schoepp, D. D. et al., "Neuroprotectant effets of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist," J. Neural Trasm. ›GenSect! 85:131-143 (1991)
• Sircar, R. and S. R. Zukin, "Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation," Brain Res. 556:280-284 (1991)
• Skilling, S. R. et al., "Differential Effects of C-and N-Terminal Substance P Metabolites on the Release of Amino Acid Neurotransmitters from the Spinal Cord: Potential Role in Nociception," J. Neurosci. 10(4):1309-1318 (1990)
• Steinberg, G. K. et al., "Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia," Neurosci. Lett. 89:193-197 (1988)
• Swinyard, E. A., "Assay of Antiepileptic Drug Activity in Experimental Animals: Standard Tests," in: Anticonvulsant Drugs, Mercier, J., ed., Pergamon Press: Oxford, pp. 47-65 (1973)
• Tamura, Y. et al., "O-Mesitylenesulfonylhydroxylamine and Related Compounds--Powerful Aminating Reagents," Synthesis 1:1-17 (1977)
• Tiseo, P. J. and C. E. Inturrisi, "Attenuation and Reversal of Morphine Tolerance by the Competitive N-Methyl-D-Aspartate Receptor Antagonist, LY274614," J. Pharmacol. Exp. Ther. 264(3):1090-1096 (Mar. 1993)
• Tomasik, P. and Z. Skrowaczewska, "Reduction of 3,5-dinitropyridine and its 2-substituted derivatives by first-order substituents. III. Reduction of 2-amino and 2-hydrazino-3,5-dinitropyridines," Chem. Abstr. 65:3826 (1966)
• Tricklebank, M. D. et al., "A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine," Eur. J. Pharmacol. 141:497-501 (1987)
• Tricklebank, M. D. et al., "The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor," Eur. J. Pharmacol. 167:127-135 (1989)
• Trujillo, K. A. and H. Akil, "Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801," Science 251:85-87 (1991)
• Watkins, J. C. and H. J. Olverman, "Agonists and antagonists for excitatory amino acid receptors," TINS 10(7):265-272 (1987)
• Way, E. L. et al., "Simultaneous Quantative Assessment of Morphine Tolerance and Physical Dependence," J. Pharmacol. Exp. Ther. 167(1):1-8 (1969)
• Weinstock, J. and R. Y. Dunoff, "Pteridines. IX. Some Pteridine Isomers of Triamterene," J. Med. Chem. 11(3):565-568 (1968)
• Willetts, J. and R. L. Balster, "The Discriminative Stimulus Effects of N-Methyl-D-Aspartate Antagonists in Phencyclidine-Trained Rats," Neuropharmacol. 27(12):1249-1256 (1988)
• Winterfield, K. and M. Wildersohn, "2,3-Dichlor-und 2,3,7-Trichlor-5-aza-chinoxalin," Archiv der Pharmazie 303:44-48 (1970)
• Wong, E. H. F. et al., "The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist," Proc. Natl. Acad. Sci. USA 83:7104-7108 (1986)
• Wong, E. H. F. and J. A. Kemp, "Sites for Antagonism on the N-Methyl-D-Aspartate Receptor Channel Complex," Annu. Rev. Pharmacol. Toxicol. 31:401-425 (1991)
• Zukin, S. R. et al., "Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors," Brain Res. 294:174-177 (1984)
• English translation of relevant sections of Japanese Patent Application No. 4-178385 (Document AP2)
• International Search Report for corresponding PCT application, PCT/US95/0021